A

Arrowhead Pharmaceuticals
D

ARWR

15.090
USD
-0.30
(-1.95%)
مفتوح الان
حجم التداول
24,598
الربح لكل سهم
-3
العائد الربحي
-
P/E
-12
حجم السوق
2,082,554,560
أصول ذات صلة
ALNY
ALNY
-2.47
(-0.85%)
286.88 USD
C
CRSP
-0.750
(-1.99%)
36.860 USD
E
EDIT
-0.11000
(-6.79%)
1.51000 USD
I
IONS
-0.385
(-1.16%)
32.880 USD
MRNA
MRNA
-1.160
(-4.28%)
25.940 USD
N
NTLA
-0.37500
(-3.96%)
9.10000 USD
REGN
REGN
-9.06
(-1.52%)
587.59 USD
S
SGMO
-0.02160
(-4.37%)
0.47240 USD
S
SRPT
-0.930
(-2.40%)
37.870 USD
VRTX
VRTX
1.29
(0.30%)
435.29 USD
المزيد
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.